These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3626589)

  • 1. Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides.
    Wynn CH; Robson B
    J Theor Biol; 1986 Nov; 123(2):221-30. PubMed ID: 3626589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of GM2 activator protein with glycosphingolipids.
    Hama Y; Li YT; Li SC
    J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of gangliosides GM1 and GM2.
    Sugimoto M; Numata M; Koike K; Nakahara Y; Ogawa T
    Carbohydr Res; 1986 Nov; 156():C1-5. PubMed ID: 3815403
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Nakamura T; Ogamo A; Li YT
    J Biol Chem; 1979 Nov; 254(21):10592-5. PubMed ID: 115863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
    Trinchera M; Ghidoni R
    J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
    Wynn CH
    Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
    Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
    Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
    Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
    J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway.
    Gouni-Berthold I; Seul C; Ko Y; Hescheler J; Sachinidis A
    Hypertension; 2001 Nov; 38(5):1030-7. PubMed ID: 11711493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 13C-N.M.R. spectra of gangliosides GM1 with those of GM1-oligosaccharide and asialo-GM1.
    Sillerud LO; Yu RK
    Carbohydr Res; 1983 Mar; 113(2):173-88. PubMed ID: 6839313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
    Miyagi T; Tsuiki S
    FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The degradative pathway of gangliosides GM1 and GM2 in Neuro2a cells by sialidase.
    Riboni L; Caminiti A; Bassi R; Tettamanti G
    J Neurochem; 1995 Jan; 64(1):451-4. PubMed ID: 7798945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses of Fluorescent Gangliosides for the Studies of Raft Domains.
    Komura N; Suzuki KGN; Ando H; Konishi M; Imamura A; Ishida H; Kusumi A; Kiso M
    Methods Enzymol; 2017; 597():239-263. PubMed ID: 28935104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein activators for the hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Li YT
    Methods Enzymol; 1982; 83():588-95. PubMed ID: 6808306
    [No Abstract]   [Full Text] [Related]  

  • 17. High-performance capillary electrophoresis of gangliosides.
    Liu YB; Chan KF
    Electrophoresis; 1991 Jun; 12(6):402-8. PubMed ID: 1889389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches in the study of ganglioside metabolism.
    Tettamanti G; Ghidoni R; Sonnino S; Chigorno V; Venerando B; Giuliani A; Fiorilli A
    Adv Exp Med Biol; 1984; 174():273-84. PubMed ID: 6377848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
    Antoine T; Priem B; Heyraud A; Greffe L; Gilbert M; Wakarchuk WW; Lam JS; Samain E
    Chembiochem; 2003 May; 4(5):406-12. PubMed ID: 12740812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging.
    Suzuki KGN; Ando H; Komura N; Fujiwara TK; Kiso M; Kusumi A
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2494-2506. PubMed ID: 28734966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.